Back
  1. Home
  2. Profile of Natacha LEROI (ULiège)
Profil

LEROI Natacha

Unilab > Laboratoire Cytogénétique

See author's contact details
Main Referenced Co-authors
Martinive, Philippe  (23)
Coucke, Philippe  (20)
Noël, Agnès  (20)
Lallemand, François  (19)
Bahri, Mohamed Ali  (14)
Main Referenced Keywords
MRI (6); radiotherapy (6); DTI (4); IVIM (4); metastasis (3);
Main Referenced Unit & Research Centers
GIGA CRC (Cyclotron Research Center) In vivo Imaging-Aging & Memory - ULiège [BE] (11)
Laboratoire d'étude des tumeurs et du developpement (1)
Laboratoire de Biologie des Tumeurs et Développement (1)
Laboratoire de recherche sur les métastases (1)
Laboratory of Tumor and Development Biology (1)
Main Referenced Disciplines
Oncology (24)
Radiology, nuclear medicine & imaging (2)
Anatomy (cytology, histology, embryology...) & physiology (1)
Biochemistry, biophysics & molecular biology (1)
Biotechnology (1)

Publications (total 32)

The most downloaded
592 downloads
Suarez-Carmona, M., Bourcy, M., LESAGE, J., Leroi, N., Syne, L., Blacher, S., Hubert, P., Erpicum, C., Foidart, J.-M., Delvenne, P., Birembaut, P., Noël, A., Polette, M., & Gilles, C. (2015). Soluble factors regulated by epithelial-mesenchymal transition mediate tumour angiogenesis and myeloid cell recruitment. Journal of Pathology, 236 (4), 491-504. doi:10.1002/path.4546 https://hdl.handle.net/2268/181994

The most cited

52 citations (OpenAlex)

Suarez-Carmona, M., Bourcy, M., LESAGE, J., Leroi, N., Syne, L., Blacher, S., Hubert, P., Erpicum, C., Foidart, J.-M., Delvenne, P., Birembaut, P., Noël, A., Polette, M., & Gilles, C. (2015). Soluble factors regulated by epithelial-mesenchymal transition mediate tumour angiogenesis and myeloid cell recruitment. Journal of Pathology, 236 (4), 491-504. doi:10.1002/path.4546 https://hdl.handle.net/2268/181994

Articles accepted in reviewed journal

Freire Chadrina, M., Martin, M., Segers, K., Sépulchre, E., LEROI, N., COUPIER, J., Kalantari, H. R., Wolter, P., Collignon, J., Polus, M., Plomteux, O., Josse, C., & Bours, V. (29 May 2024). Digenic Inheritance of Mutations in Homologous Recombination Genes in Cancer Patients. Journal of Personalized Medicine, 14 (6), 584. doi:10.3390/jpm14060584
Peer Reviewed verified by ORBi

Streel, S.* , Salmon, A.* , DHEUR, A., Bours, V., LEROI, N., Habran, L., Delbecque, K., Goffin, F., PLEYERS, C., Kakkos, A., Gonne, E., Seidel, L., Kridelka, F.* , & Gennigens, C.*. (02 March 2023). Diagnostic Performance of Immunohistochemistry Compared to Molecular Techniques for Microsatellite Instability and p53 Mutation Detection in Endometrial Cancer. International Journal of Molecular Sciences, 24 (5), 4866. doi:10.3390/ijms24054866
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Freire, M. V., MARTIN, M., Thissen, R., Van Marcke, C., SEGERS, K., SEPULCHRE, E., LEROI, N., LETE, C., FASQUELLE, C., Radermacher, J., Gokburun, Y., COLLIGNON, J., Sacré, A., JOSSE, C., PALMEIRA, L., & BOURS, V. (2022). Case Report Series: Aggressive HR Deficient Colorectal Cancers Related to BRCA1 Pathogenic Germline Variants. Frontiers in Oncology, 12, 835581. doi:10.3389/fonc.2022.835581
Peer Reviewed verified by ORBi

LALLEMAND, F., LEROI, N., Blacher, S., Bahri, M. A., Balteau, E., COUCKE, P., Noël, A., Plenevaux, A., & Martinive, P. (2021). Tumor Microenvironment Modifications Recorded With IVIM Perfusion Analysis and DCE-MRI After Neoadjuvant Radiotherapy: A Preclinical Study. Frontiers in Oncology. doi:10.3389/fonc.2021.784437
Peer Reviewed verified by ORBi

DOCAMPO MARTINEZ, E., MARTIN, M., GANGOLF, M., HARVENGT, J., BULK, S., SEGERS, K., LEROI, N., LETE, C., PALMARICCIOTTI, V., Freire Chadrina, M., LAMBERT, F., & Bours, V. (2021). Hérédité et cancer. Revue Médicale de Liège, 76 (5-6), 327-336.
Peer reviewed

Nagachinta, S., Becker, G., Dammicco, S., Serrano Navacerrada, M. E., LEROI, N., Bahri, M. A., Plenevaux, A., Lemaire, C., Lopez, R., Luxen, A., & de la Fuente, M. (2020). Radiolabelling of lipid-based nanocarriers with fluorine-18 for in vivo tracking by PET. Colloids and Surfaces B: Biointerfaces, 188, 110793. doi:10.1016/j.colsurfb.2020.110793
Peer Reviewed verified by ORBi

Goux, M., Becker, G., Gorré, H., Dammicco, S., Desselle, A., Egrise, D., Leroi, N., Lallemand, F., Bahri, M. A., Doumont, G., Plenevaux, A., Cinier, M., & Luxen, A. (21 August 2017). Nanofitin as a New Molecular-Imaging Agent for the Diagnosis of 2 Epidermal Growth Factor Receptor Over-Expressing Tumors. Bioconjugate Chemistry, 28 (9), 2361-2371. doi:10.1021/acs.bioconjchem.7b00374
Peer Reviewed verified by ORBi

Henry, A., Nokin, M.-J., Leroi, N., Lallemand, F., Lambert, J., Goffart, N., RONCARATI, P., BIANCHI, E., Peixoto, P., Blomme, A., Turtoi, A., Peulen, O., Habraken, Y., Scholtes, F., Martinive, P., Delvenne, P., Rogister, B., Castronovo, V., & Bellahcene, A. (2016). New role of osteopontin in DNA repair and impact on human glioblastoma radiosensitivity. Oncotarget. doi:10.18632/oncotarget.11483
Peer Reviewed verified by ORBi

Leroi, N., LALLEMAND, F., COUCKE, P., Noël, A., & MARTINIVE, P. (30 March 2016). Impacts of Ionizing Radiation on the Different Compartments of the Tumor Microenvironment. Frontiers in Pharmacology, 7, 1-9. doi:10.3389/fphar.2016.00078
Peer Reviewed verified by ORBi

Leroi, N., Sounni, N. E., Van Overmeire, E., Blacher, S., Marée, R., Van Ginderachter, J., Lallemand, F., LENAERTS, E., COUCKE, P., Noël, A.* , & MARTINIVE, P.*. (2015). The timing of surgery after neoadjuvant radiotherapy influences tumor dissemination in a preclinical model. Oncotarget. doi:10.18632/oncotarget.5931
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Suarez-Carmona, M., Bourcy, M., LESAGE, J., Leroi, N., Syne, L., Blacher, S., Hubert, P., Erpicum, C., Foidart, J.-M., Delvenne, P., Birembaut, P., Noël, A., Polette, M., & Gilles, C. (2015). Soluble factors regulated by epithelial-mesenchymal transition mediate tumour angiogenesis and myeloid cell recruitment. Journal of Pathology, 236 (4), 491-504. doi:10.1002/path.4546
Peer Reviewed verified by ORBi

Articles accepted in conference proceedings

LALLEMAND, F., LEROI, N., Bahri, M. A., Balteau, E., Noël, A., Coucke, P., Plenevaux, A., & Martinive, P. (April 2019). Tumor modifications recorded with IVIM and DCE-MRI after Neoadjuvant radiotherapy. Radiotherapy and Oncology, 133 (Supplement 1), 284 - S285. doi:10.1016/S0167-8140(19)30960-0
Peer Reviewed verified by ORBi

LALLEMAND, F., LEROI, N., Bahri, M. A., Balteau, E., Noël, A., Coucke, P., Plenevaux, A., & Martinive, P. (April 2018). Brain modifications after stereotactic radiotherapy recorded by Functional MRI. Radiotherapy and Oncology, 127 (Supplement 1), 582. doi:10.1016/S0167-8140(18)31346-X
Peer Reviewed verified by ORBi

LALLEMAND, F., LEROI, N., Bahri, M. A., Balteau, E., Noël, A., Coucke, P., Plenevaux, A., & Martinive, P. (April 2018). Tumor microenvironment modifications recorded with IVIM perfusion analysis after radiotherapy. Radiotherapy and Oncology, 127 (Supplement 1), 1285-S1286. doi:10.1016/S0167-8140(18)32640-9
Peer Reviewed verified by ORBi

LALLEMAND, F., LEROI, N., Bahri, M. A., Balteau, E., Noël, A., Coucke, P., Plenevaux, A., & Martinive, P. (May 2017). Following tumour microenvironment after Neoadjuvant radiotherapy with IVIM perfusion analysis. Radiotherapy and Oncology, 123 (Supplement 1), 545. doi:10.1016/S0167-8140(17)31424-X
Peer Reviewed verified by ORBi

LALLEMAND, F., Leroi, N., Bahri, M. A., Balteau, E., Noël, A., COUCKE, P., MARTINIVE, P., & Plenevaux, A. (2016). Diffusion MRI for following tumor modifications after neoadjuvant radiotherapy. Radiotherapy and Oncology, 119, 966-S967.
Peer Reviewed verified by ORBi

LALLEMAND, F., Leroi, N., Bahri, M. A., Balteau, E., Noël, A., COUCKE, P., MARTINIVE, P., & Plenevaux, A. (April 2015). Functional MRI for predicting metastatic spreading at the time of surgery after neoadjuvant radiotherapy. Radiotherapy and Oncology, 115 (Supplement 1), 832-S833. doi:10.1016/S0167-8140(15)41518-X
Peer Reviewed verified by ORBi

Contact ORBi